A Phase 1 Study Of Parsaclisib In Combination With Rituximab, Bendamustine + Rituximab, Or Ibrutinib In Patients With Previously Treated B-Cell Lymphoma (Citadel-112): Preliminary Safety Results
Bendamustine;Ibrutinib;Parsaclisib;Rituximab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Phase 1 Study Of Parsaclisib In Combination With Rituximab, Bendamustine + Rituximab, Or Ibrutinib In Patients With Previously Treated B-Cell Lymphoma (Citadel-112): Preliminary Safety Results ### Output: Bendamustine;Ibrutinib;Parsaclisib;Rituximab